check their press release of 2 days ago. Remember too, in cancer drugs, if you can stop or even slow down disease progress for 2.5 to 4 months longer than can the current standard of care drug, you stand a very good chance of FDA approval. 3 to 4 months almost certainly, all other things being equal.
Cancers are a fatal disease (s) Alzheimers is a fatal disease. Nothing on the market can slow it down more than 3 to 5 months, and that is with some of the patients and just barely for them, ALMOST IMPERCEPTIVELY, EVER SO SLIGHTLY, and then the existing drugs fall off a cliff.
Personally, I really like both commpanies. Before here it was all this nonsense after 'fraud ' data in a paper or inkblot from 10 years ago, a disrepetuble ceo, etc, based on nothing but fraud short sellers, the same people who went after avxl 4 years ago, but here, because it is now another company (a competitor btw!)...everybody goes muckraking gonzo, showing how their minds work, which si the way it is with people........people here complain unendingly about dr. M over the past 3 or 4 years; I think Dr. M is a terrific ceo but not perfect in hindsight........People will say anything to support their entrenched emotional positions...almost
As General Buck "Turgidson" said in the movie Doctor Strangelove, "but just look at the big board!" --
It is sad but also amusing, reminds me of the thousand hostile or opposing witnesses I used to cross on the witness stand. So much fun! The juries and judges had a gas.
People here trumpet the arrival of mutual fund money into Anavex, where the buyers are sophisticated, taking advantage of various forms of expertise, but when they are pointd out, sava has more such fund owners in sava, they cry like Mr MaGoo scrooge, HUMBUG,-the people are in need of clairvoyant statistics subtleties....
like you cannot bear your kid got into william and mary, but the kid up the street got into yale.
News 
Market Data 
Discover 
AI
